Clinical Trials Logo

Clinical Trial Summary

By this non-randomized prospective study, it's evaluated the outcome of patients underwent BCS for DCIS at whom an established score system to address adjuvant therapies have been prospectively applied, according to the wideness of free margins.

Between March 2000 and April 2006, 224 patients were enrolled and followed within the study.

Clinical Trial Description


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

NCT number NCT03002766
Study type Interventional
Source Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status Completed
Phase Phase 2
Start date March 2000
Completion date April 2006

See also
  Status Clinical Trial Phase
Completed NCT01849133 - Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External Radiotherapy N/A
Recruiting NCT04790305 - Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer Phase 4
Completed NCT03113825 - Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery Phase 2
Recruiting NCT03768492 - Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy Phase 2
Not yet recruiting NCT04410224 - Study of ASN004 in Patients With Advanced Solid Tumors Phase 1